Skip to content

Released Mar 6, 2019, before the open

10-K filed Mar 6, 2019, 65 days after period end · 0001144204-19-012434

Q4 2018 · 10-K
Revenue$0.00— vs Q4 2017no prior Q3 2018 on file
Net Income-$3.23MN/M vs Q4 2017N/M vs Q3 2018
EPS Diluted-$0.15N/M vs Q4 2017N/M vs Q3 2018
Operating Income-$3,171,367N/M
Operating Cash Flowderived-$2,232,827N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2018Q4 2017Q4 2016Q4 2015
Revenue$0.00$0.00——
Net Income-$3.23M-$5.33M-$2.97M-$4.63M
EPS Diluted-$0.15-$0.25-$0.16-$0.25

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR